Everand Logo

Welcome to Everand!

  • STAT

    After Trump’s election, long-acting contraceptive use jumped among women with private insurance

    In the days after Donald Trump was elected, news outlets picked up on what seemed to be a trend: Women were rushing to get long-acting contraception. Now, a new study…
    by Megan Thielking Feb 04, 2019 2 minutes

    In the days after Donald Trump was elected, news outlets picked up on what seemed to be a trend: Women, fearing new restrictions on birth control access or changes to the Affordable Care Act, were rushing to get intrauterine devices and other types of long-acting contraception.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

    Related Books & Audiobooks